Bull Rankings model

Uranium Royalty Corp. (UROY) stock analysis

Uranium. Scored on the same transparent model behind the daily rankings.

★
UROY
Uranium Royalty Corp. · Uranium
23.0Score
$4.18Oct 9 close$1.6B
1Y Target$4.19Analyst consensus · 3 analysts
5Y Target$5.29Compound horizon
10Y Target$6.78Long-dated conviction
FCF$208mTTM · 07/26
C
FCF $208m — modest; watch for margin expansion · Trailing twelve months to 07/26 (operating cash flow − capex).
Rev*—
—
Revenue growth n/a — over 500% off a tiny base, too distorted to grade
D/E0.56
B
D/E 0.56 — near the Energy debt median (≈60th pctile)
P/E11.0x
B+
P/E 11.0 — below the Energy median (≈40th pctile)
PEG*—
—
PEG n/a — analysts expect next year's earnings to be no higher than last year's

* Revenue growth n/a — over 500% off a tiny base, too distorted to grade

* PEG n/a — analysts expect next year's earnings to be no higher than last year's

Targets: 1-year is analyst consensus where covered, 5- and 10-year are model estimates; the DCF is a cross-check, not a target. Methodology

Quality-growth score · 23
Quality50.6
Growth9.5
Value25.4
Why this score
  • Diluting shareholders
  • Short track record
Entry · Margin of safety
52-week rangeMid-range
24% off the 12-month high
vs DCF fair value8% belowest. fair value ~$5
What the price assumes: free cash flow shrinking about 4% next year, then recovering toward 4% a year by year ten — vs a starting rate of ~-5% our model takes as the middle of three readings — analyst estimates, last year's revenue growth, and the company's own multi-year record.

Model-generatedFrom reported fundamentals, checked against the figures above · Editorial standards

Why now
Uranium · market cap $1.6b. Down 24% from 52-week high of $5.52 — deep drawdown territory. 3 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $4.19 (implying +0% upside).
Moat
Net margin 26% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. Free cash flow runs well ahead of reported net income, mostly because of cash released from working capital ($167m, chiefly inventory sold down) — a release that doesn't repeat every year the way earnings can.
Risk
Beta 1.58 implies above-market volatility — position-size to the drawdowns this name will produce in a market correction, not to its bull-case return.
Horizon
1-3 yr $4.19 (3-analyst consensus) — multiple re-rating thesis requires a catalyst. 5 yr $5.29 at ~5% CAGR — earnings growth has to outrun share dilution. 10 yr $6.78 if the moat survives secular pressure.

UROY vs the Top Picks average

PillarUROYBook avgDiff
Quality5183-32
Growth1089-79
Value2576-51

Average of today's Top 30 (mean score 82.6); size and sector limits also decide the book.

Trend
-16.4 over 47 daily scores
From 39.4 (Aug 7) → 23.0 (now)

One point per daily run; read From → To for the actual range.

UROY at a glance

THE BULL RANKINGS SCORECARD23.0/ 100 · BULL SCOREPEER MEDIANQUALITY50.6GROWTH9.5VALUE25.4Reverse-DCF · Price implies roughly no growth from here.
PRICE vs OUR DCF FAIR VALUE$4$5.1FAIR-VALUE RANGE$4.2PRICEOur DCF fair value ~$4.6 · price $4.2 is 8% below it.
WHERE THIS SCORE SITS0255075100UROY 23.0Ranks above 12% of 1,709 companies on the quality-growth score.
PRICE IN ITS 52-WEEK RANGE$4.2LOW $2.6HIGH $5.5Trading at the 55th percentile of its 52-week range ($2.6–$5.5).

Same audited fundamentals as the score, unless a card says otherwise.

Analyst estimate revisions

30-day change-3.1%
90-day change-1.8%
Forward EPS estimate$0.03

Over the last 90 days, what analysts expect UROY to earn is drifting lower (-1.8%). The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.

A fiscal-year roll fell inside this window: the forward horizon moved on to the next financial year, which shifts the earnings figure without any analyst changing their view. That step is excluded, so the number above covers the rest of the window rather than all of it.

Estimates move both ways and are not part of the Bull Rankings score. Biggest movers →

Shares to buy
478
Position size
$1,998
4.0% of portfolio
Stop price
$3.13
25% below $4.18
$ at risk if stopped
$499.51
budget $500.00 · 1% of portfolio

Math only: excludes commissions, slippage and gap risk. Inputs stay in your browser.

Uranium Royalty Corp. (UROY): score, valuation & FAQ

Uranium Royalty Corp. (UROY) is a Uranium company that scores 23 out of 100 on the Bull Rankings quality-growth model — a weak reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.

Its strongest graded signals are P/E (B+). On valuation, UROY sits about 8% below our discounted-cash-flow fair value (a margin of safety) — the current price implies free cash flow shrinking about 4% next year, then recovering toward 4% a year by year ten.

Is UROY a good stock to buy?

Bull Rankings scores UROY 23 out of 100 on its quality-growth model, which is a weak reading. That is driven by P/E (B+). A score is a quantitative screen of Uranium Royalty Corp.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.

Why does UROY score 23 on Bull Rankings?

The score leans on quality at 50.6 out of 100, with growth the weakest pillar at 9.5 — the three combine geometrically, so a weak one cannot be papered over by a strong one. UROY earns its highest marks on P/E (B+). Each signal is graded against sector-aware thresholds rather than one absolute bar, so UROY is measured against Uranium peers, not against the market as a whole.

Is UROY overvalued or undervalued?

Based on $4.18, UROY sits about 8% below our discounted-cash-flow fair value (a margin of safety) — the current price implies free cash flow shrinking about 4% next year, then recovering toward 4% a year by year ten. It trades at an 11.0x P/E (graded B+). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.

What are the main risks of investing in UROY?

Beta 1.58 implies above-market volatility — position-size to the drawdowns this name will produce in a market correction, not to its bull-case return.

New to these metrics? See the guides and the methodology.

More Coal & Uranium stocks by score

All Energy rankings →

Analyze another ticker →